Effect of Human Immunodeficiency Virus on the Outcome of Hepatitis C Virus Infection

References

• Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26: 62S–5S.
   Google Scholar
• Smith DB, Pontisso P. Heterogeneity of hepatitis C virus. Bailliere’s Clinical Gastroenterol 1996;10:243–56.
   PubMed Web of Science ®Google Scholar
• Simmonds P, Holmes E, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 1993;74:2391–9.
   PubMed Web of Science ®Google Scholar
• Rockstroh JK, Woitas RP, Spengler U. Human immunodeficiency virus and hepatitis C virus co-infection. Eur J Med Res 1998;3:269–77.
   Google Scholar
• Temin H. Retrovirus variation and reverse transcription: abnormal strands transfers result in genetic variation. Proc Natl Acad Sci USA 1993;90:6900–3.
   PubMed Web of Science ®Google Scholar
• Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infection. Clin Infec Dis 1996;23:1117–25.
   PubMed Web of Science ®Google Scholar
• Soriano V, Rodriguez-Rosado R, Garcia-Samniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS 1999;13:539–46.
   PubMed Web of Science ®Google Scholar
• Sheeff LB. Natural history of hepatitis C. Hepatology 1997;26: 21S–8S.
   Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556–62.
   PubMed Web of Science ®Google Scholar
• McNair AN, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992;12:188–96.
   Google Scholar
• Dieterich DT, Purow JM, Rajapaksa R. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV. Semin Liver Dis 1999;19:87S–94S.
   Google Scholar
• Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. J Hepatol 1997;27:18–24.
   PubMed Web of Science ®Google Scholar
• Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patients survival. Hepatology 1994;20:1152–5.
   PubMed Web of Science ®Google Scholar
• Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Substance Use Misuse 1998;33:1197–12.
   PubMed Web of Science ®Google Scholar
• Tillmann HL, Manns MP. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci 1996;41:27S–40S.
   Google Scholar
• Yerly S, Pedrocchi M, Perrin L. The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNA. Transfusion 1998;38: 908–14.
   Google Scholar
• Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685–90.
   PubMed Web of Science ®Google Scholar
• Lefrere JJ, Cantaloube JF, Defer C, Mercier B, Loiseau P, Vignon D, et al. Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing. J Virol Methods 1999;80:33–44.
   PubMed Web of Science ®Google Scholar
• Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among heath care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994;170:1410–7.
   PubMed Web of Science ®Google Scholar
• Busch MP, Lee LLL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91–7.
   PubMed Web of Science ®Google Scholar
• Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case control study of a HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485–90.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine 1995;74:212–20.
   PubMed Web of Science ®Google Scholar
• Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of co-infection with human immunodeficiency virus. J AIDS 1993;6:602–10.
   PubMed Web of Science ®Google Scholar
• Dienstag JL. Sexual and perinatal transmission of hepatitis C. Hepatology 1997;26:66S–70S.
   Google Scholar
• Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, et al. Transmission of hepatitis C virus from mother to infants. N Engl J Med 1994;330:744–50.
   PubMed Web of Science ®Google Scholar
• Papaevangelou V, Pollack H, Rochford G, Kokka R, Hou Z, Chernoff D, et al. Increased transmission of vertical hepatitis C virus infection to human immunodeficiency virus-infected infants of HIV and HCV co-infected women. J Infection 1998;178:47–1052.
   Google Scholar
• Hershow RC, Riester KA, Lew J, Quinn TC, Mofenson LM, Davenny K, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus co-infected mothers. J Infect 1997;176:414–20.
   Google Scholar
• Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother to child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000;356:904–7.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998;27:108–17.
   Google Scholar
• Telfer PT, Brown D, Devereux H, Lee CA, DuSheiko GM. HCV-RNA levels and HIV infection. Br J Haematol 1994;88: 397–9.
   PubMed Web of Science ®Google Scholar
• Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients co-infected with HIV. AIDS 1995;9:1131–36.
   Google Scholar
• Giovannini M, Tagger A, Ribero ML, Zuccotti G, Pogliani L, Grossi A, et al. Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction. Lancet 1990;335: 1166–7.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, et al. Mother to infant transmission of hepatitis C virus. Lancet 1995;345:289–91.
   PubMed Web of Science ®Google Scholar
• Lin HH, Kao JH, Hsu HY, Ni YH, Chang MH, Huang SC, et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995;126:589–91.
   PubMed Web of Science ®Google Scholar
• European Collaborative study. Risk factors for mother to child transmission of HIV-1. Lancet 1992;339:1007–12.
   PubMed Web of Science ®Google Scholar
• Ndimbie OK, Kingsley LA, Nedjar S, Rinaldo CR. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996;72:213–6.
   PubMedGoogle Scholar
• Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993;269:392–4.
   PubMed Web of Science ®Google Scholar
• Rockstroh JK, Ewig S, Bauer T, Luchters G, Oldenburg J, Bailly E, et al. Male to female transmission of HIV in a cohort of hemophiliacs frequency, risk factors, and effect of sexual counseling. Infection 1995;23:29–32.
   PubMed Web of Science ®Google Scholar
• Soto B, Rodrigo L, Garcia-Bengoechea M, Sanchez-Quijano A, Riestra S, Arenas JI, et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case: a multicentre study of 423 pairings. J Intern Med 1994;236: 515–9.
   Google Scholar
• Ndimbie OK, Kignsley LA, Nedjar S, Rinaldo CR. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996;72:213–6.
   PubMedGoogle Scholar
• Lok A, Chien D, Choo Q, Chan TM, Chiu EK, Cheng IK, et al. Antibody response the core, envelope and nonstructural hepatitis C antigens: comparison of immunocompetent and immunosup-pressed patients. Hepatology 1993;18:497–502.
   PubMed Web of Science ®Google Scholar
• Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology 1998;27:2–6.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174:690–5.
   PubMed Web of Science ®Google Scholar
• Chamot E, Hirschel B, Wintsch J, Robert CF, Gabriel V, Deglon JJ, et al. Loss of antibodies against hepatitis C virus in HIV seropositive intravenous drug users. AIDS 1990;4:1275–7.
   PubMed Web of Science ®Google Scholar
• Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. The presence of hepatitis C virus antibody in human immunodeficiency virus positive hemophiliac men undergoing HCV-seroreversion. Blood 1993,82:1010–5.
   Google Scholar
• Libanore M, Bicocchi R, Sighinolfi L, Ghinelli F. Fulminant NANB hepatitis in a patient with AIDS: a possible demonstration of direct hepatic damage by the virus/es involved? Infection 1988;16:255–7.
   PubMed Web of Science ®Google Scholar
• Garcia-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A, Carbo J, et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol 1997;92:1130–4.
   Google Scholar
• Pol S, Thiers V, Nusbaum JB. Changing distribution of HCV-genotypes in Europe in the last decades. J Hepatol 1994;20:13S–20S.
   Google Scholar
• Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998;12:387–8.
   Google Scholar
• Piroth L, Bourgeois C, Dantin S, Waldner A, Grappin M, Portier H, et al. Hepatitis C virus genotype does not appear to be a significant prognostic factor in HIV-HCV co-infected patients. AIDS 1999;13:523–37.
   PubMed Web of Science ®Google Scholar
• Cribier B, Schmitt C, Rey D, Uhl G, Lang JM, Vetter D, et al. HIV increases hepatitis C viremia irrespective of the hepatitis C virus genotype. Res Virol 1997;148:267–71.
   PubMedGoogle Scholar
• Sabin C, Telter P, Phillips A, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophiliac men. J Infect Dis 1997;175:164–8.
   Google Scholar
• Bierhoff E, Fischer HP, Willsch E, Rockstroh J, Spengler U, Brackmann HH, et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 1997;430:271–7.
   PubMed Web of Science ®Google Scholar
• Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. Hepatology 1999;30:1054–8.
   PubMed Web of Science ®Google Scholar
• Boldorini R, Vigano P, Monga G, Nebuloni M, Cargnel A, Gubertini G, et al. Hepatic histology of patients with HIV infection and chronic hepatitis C treated with interferon. J Clin Pathol 1997;50:735–40.
   PubMed Web of Science ®Google Scholar
• Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1–5.
   PubMed Web of Science ®Google Scholar
• Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Phys 1999;111:563–72.
   PubMedGoogle Scholar
• Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of Hepatitis B and C induced hepatocellular carcinoma. J Viral Hepatitis 1998;5:285–99.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Imamura A, Masuda G, Ajisawa A, Negishi M, Tanaka S, et al. A case of hepatocellular carcinoma in HIV-infected patients. Hepatogastroenterology 1996;43:1067–72.
   PubMedGoogle Scholar
• Cooksley W. Chronic liver disease: do alcohol and hepatitis C virus interact. J Gastroenterol Hepatol 1996;11:187–92.
   PubMed Web of Science ®Google Scholar
• Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671–5.
   PubMed Web of Science ®Google Scholar
• Weinig M, Hakim JG, Gudza I, Tobaiwa O. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study. Trans R Soc Trop Med Hyg 1997; 91:570–2.
   PubMed Web of Science ®Google Scholar
• Staples CT, Rimland JD, Dudas D. Hepatitis C in the HIV Atlanta VA cohort study: the effect of co-infection on survival. Clin Infect Dis 1999;29:150–4.
   PubMed Web of Science ®Google Scholar
• Dorrucci M, Pezzotti P, Philips AN, Lepri AC, Rezza G. Co-infection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis 1995;172: 1503–8.
   Google Scholar
• Idilman R, De Maria N, Colantoni A, Dokmeci A, Van Thiel DH. Interferon treatment of cirrhotic patients with chronic hepatitis C. J Viral Hepatitis 1997;4:81–91.
   PubMed Web of Science ®Google Scholar
• Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986;6:1038–41.
   PubMed Web of Science ®Google Scholar
• Van Thiel DH, De Maria N, Colantoni A, Idilman R. Current and future therapies for HCV infection: what should the end point for treatment be? Hepatogastroenterology 1998;45:308–20.
   PubMedGoogle Scholar
• Patterson JL, Fernandez-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infect Dis 1990;12:1139–46.
   PubMedGoogle Scholar
• Reichard O, Schvarcz R, Weiland O. Therapy of hepatitis C: ribavirin treatment alone or in combination with interferon. Hepatology 1997;26:108S–11S.
   Google Scholar
• Davis GL. Combination treatment with interferon and ribavirin for chronic hepatitis C. Clinic in Liver Disease 1999;3:811–26.
   PubMedGoogle Scholar
• EASL International Consensus Conference on hepatitis C. J Hepatol 1999;30:956–61.
   PubMedGoogle Scholar
• Weiland O. Treatment of naive patients with chronic hepatitis C. J Hepatol 1991;31:168–73.
   Google Scholar
• Marcellin P, Boyer N, Areias J, Erlinger S, Benhamou JP. Comparison of efficacy of alpha interferon in former intravenous drug addicts with chronic hepatitis C with or without HIV infection. Gastroenterology 1994;106:938A.
   Google Scholar
• Pol S, Trinh T, Thiers V, Jaffredo F, Carnot F, Lamorthe B, et al. Chronic hepatitis of drug users: influence of HIV infection. Hepatology 1995;20:340A. Abstract 933.
   Google Scholar
• Mauss S, Heintges T, Adams O, Albrecht H, Niederau C, Jablonowski H. Treatment of chronic hepatitis C with interferon-a in patients infected with the human immunodeficiency virus. Hepato-Gastroenterol. 1995;42:528–34.
   PubMed Web of Science ®Google Scholar
• Soriano V, Garcia-Samaniego J, Bravo R, Gonzalez J, Castro A, Castilla J, et al. Interferon-α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin Infec Dis 1996;23:585–91.
   PubMed Web of Science ®Google Scholar
• Fernandez-Larsson R, Patterson JL. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. Monocular Pharmol 1990;38: 766–70.
   Google Scholar
• Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infec Dis 1998;177:783–5.
   PubMed Web of Science ®Google Scholar
• Sherman KE, O’Brien J, Gutierrez G, Harrison S, Urdea M, Neuwald P, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993;31:2679–82.
   PubMed Web of Science ®Google Scholar
• Gavazzi G, Bouchard O, Leclercq P, Morel-Baccard C, Bosseray A, Dutertre N, et al. Change in transaminases in hepatitis C virus and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologie responders. AIDS Res Hum Retroviruses 2000;16: 1021–3.
   Google Scholar
• John M, Flexman J, French MAH. Hepatitis C virus-associated hepatitis following treatment of HIV-infeeted patients with HIV protease inhibitors: an immune restoration disease? AIDS 1998; 12:2289–93.
   Google Scholar
• French MAH, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell mediated immunity to mycobacteria in immunodeficient HIV infected patients. AIDS 1992;6:1293–7.
   Google Scholar
• Poles MA, Dieterich DT. Hepatitis C virus/human immunodeficiency virus co-infection: clinical management issues. Clin Infect Dis 2000;31:154–61.
   PubMed Web of Science ®Google Scholar
• Markowitz M, Saag M, Powderly WG, Hurley AM, Hsu A, Valdes JM, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333:1534–9.
   PubMed Web of Science ®Google Scholar
• Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravcik S, Maurath C, et al. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet 1998;351:543–9.
   PubMed Web of Science ®Google Scholar
• Karras A, Rabian C, Zylberberg H, Hermine O, Duchatelle V, Durand F, et al. Severe anoxic hepatic necrosis in an HIV-1 hepatitis C virus co-infected patient starting antiretroviral triple combination therapy [letter]. AIDS 1998;12:827–9.
   PubMedGoogle Scholar
• Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74–80.
   PubMed Web of Science ®Google Scholar